Industry: Pharmaceuticals, Biotechnology
Phylogix, Inc. is an early-stage biotechnology company developing an innovative class of lectin-based drugs focused on tissue protection and oncology. The Company has a lead drug candidate in preclinical development, called FRIL, that addresses a critical unmet need to protect cancer patients from the toxic side-effects of chemotherapy. The Company believes FRIL has additional therapeutic applications in oncology and immunology, currently at the research stage, and an emerging plant drug platform that capitalizes on the ability to shuffle the binding and effector domains of this class of plant proteins to create novel, high-value drugs. ( www.phylogix.com )
Phylogix , Inc.
100 Beaver Street
Waltham, Massachusetts 02453
USA
Tel: (781) 419-8000